“…Extensive axonal degeneration (Bigler, 1987;Ding et al, 2008;Mamere et al, 2009) and generalized cerebral atrophy (MacKenzie et al, 2002;Sidaros et al, 2009;Trivedi et al, 2007) associated with poor functional outcomes are the common sequelae. TBI-induced hypoperfusion, which could occur beyond the site of primary injury (Bonne et al, 2003;Hofman et al, 2001;Pasco et al, 2007), aggravates this trauma-triggered brain damage. To date, however, the management of patients with TBI has generally concentrated on the prevention or amelioration of such devastating secondary Although mechanisms responsible for the observed therapeutic potential of MSCs remain to be explored, it is suggested that the beneficial effects are owed to the ability of MSCs to secrete an array of cytokines and trophic factors that activate endogenous restorative and regenerative processes, e.g., angiogenesis, synaptogenesis, gliogenesis, and neurogenesis (Chopp and Li, 2006;Mahmood et al, 2004aMahmood et al, , 2004b.…”